Physicians have launched the world’s first mRNA lung cancer vaccine trial, marking a significant advancement in cancer treatment.
BioNTech developed the vaccine BNT116, which targets non-small cell lung cancer (NSCLC) by training the immune system to identify and attack tumor markers.
Conducted across seven countries, including Türkiye, the phase 1 trial involves 130 patients with varying stages of lung cancer and aims to eliminate cancer cells and prevent recurrence.
The trial uses mRNA technology similar to that in COVID-19 vaccines, potentially offering a less toxic alternative to traditional chemotherapy.
Experts view this trial as a groundbreaking step in cancer research, with the first patient in the UK receiving the vaccine recently.
Source : PhilNews24 | August 24, 2024
WORLD’S INITIAL LUNG CANCER VACCINE TRIAL KICKS OFF
Latest from News
Foreign Affairs Secretary Ma. Theresa Lazaro raised the Philippines’ strong protest over China’s recent actions in
US Secretary of State Marco Rubio met with President Ferdinand Marcos Jr. during his visit to
Angat Dam’s water level dropped to a record-low 152.12 meters, surpassing the previous low recorded during
The latest Pulse Asia survey showed Senator Christopher “Bong” Go leading early vice presidential preferences for
Authorities seized frozen meat products worth P23.27 million imported from China during an inspection at the